#liver cancer

An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.

The debut of guidance from the World Health Organization includes self-testing for hepatitis C virus. [VIDEO]

In a small study, 80% of participants treated with Cabometyx and Opdivo underwent successful surgery.

People under 50 who were cured of hepatitis C were at comparable risk to the general population.

Study finds that lean people with NAFLD had a higher risk for liver events, cancer and mortality.

People treated with direct-acting antivirals had better overall survival than those whose hepatitis C remained untreated.

Barriers still stand in the way of making treatment available to all who need it.

But a simple improvement in dietary intake reversed fatty liver disease and staved off cancer.

Follow up physician visits and tests after being cured from Hepatitis C treatment can be life saving.

People who drastically reduced calories twice a week also saw reductions in liver stiffness and body weight.

Sintilimab plus chemotherapy infused into a liver artery may offer the chance for a cure.

One in five deaths among low-income adults with advanced fibrosis could be averted if they had access to adequate food.

Disruptions in access to treatment and harm reduction services could set back effort to eliminate hep C in the U.S.

An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.

Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.

The early cancer is detected, the easier it is to treat.